The hidden cost of lifesaving diabetes drugs
The stark reality we're facing is that if the cost of Ozempic and Wegovy doesn't drop, countless Americans with diabetes and obesity might be priced out of crucial treatments. Doctors are sounding the alarm, particularly for lower-income and minority communities, who are disproportionately affected. The consequences aren't just financial; they're…























